Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · IEX Real-Time Price · USD
0.260
+0.003 (1.01%)
At close: May 2, 2024, 4:00 PM
0.250
-0.010 (-3.70%)
After-hours: May 3, 2024, 5:34 PM EDT
Mangoceuticals Revenue
In the year 2023, Mangoceuticals had annual revenue of $731.49K with 8,083.16% growth. Revenue in the quarter ending December 31, 2023 was $244.37K with 2,633.80% year-over-year growth.
Revenue (ttm)
$731.49K
Revenue Growth
+8,083.16%
P/S Ratio
8.52
Revenue / Employee
$243,831
Employees
3
Market Cap
6.24M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 731.49K | 722.55K | 8,083.16% |
Dec 31, 2022 | 8.94K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGRX News
- 3 days ago - Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - GlobeNewsWire
- 23 days ago - Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products - GlobeNewsWire
- 7 weeks ago - MangoRx Officially Launches ‘PRIME' by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment - GlobeNewsWire
- 2 months ago - MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth - GlobeNewsWire
- 3 months ago - MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE - GlobeNewsWire
- 3 months ago - MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product - GlobeNewsWire
- 3 months ago - MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11 - GlobeNewsWire
- 5 months ago - Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering - GlobeNewsWire